INTEGRIS Health Partners

Letter from the President

Happy New Year to you all!
2018 saw a lot of significant changes across INTEGRIS. We welcomed new leadership and we said goodbye to some familiar faces. As the psychologist Abraham Maslow stated, “In any given moment, we have two options, to step forward into growth or step back into safety.” I think it’s fair to say that INTEGRIS is making the commitment to step forward into growth. With that being said, IHP will continue to be a catalyst for growth to tackle the ever-changing landscape of healthcare.

Despite all the uneasiness of the past year, INTEGRIS Health Partners saw some significant successes in 2018. This past year may turn out to be our best performance yet. The three health plans our network participates are showing exceptional quality metric scores showcasing the foundation we’ve long-established for delivering high-quality care. All of our participating health plans have achieved impressive scorecards in both quality and operations. The INTEGRIS Health Plan scorecard is enclosed in this newsletter. It’s worth reviewing. The scorecard for our other health plans mirror these results. More and more it looks like this quality work will translate into significant financial success. We won’t know the final outcome of shared savings until the summer, but all indications are suggesting we will have a strong operational performance.

With these positive results, I wanted to give a “shout out” to our care coordinators and population health coordinators. Our team is second-to-none. They deserve a huge thank you from all of us for providing the support and processes that makes these results possible. They have shown time and again that they are highly skilled and extremely dedicated to making the patient experience the best it can be.

New leadership for INTEGRIS will lead to new opportunities, new strategies, and new ways of looking at what we do. As the year goes on, I think our strategic vision will become more focused, and this will lead to a clearer pathway for continued success. I will always keep you up-to-date on what we are doing and what our plan is. I know many of you are anxious about the new executive leadership make up and changes in the INTEGRIS leadership structure. Our new CEO, Tim Pehrson, has expressed that physician leadership is vitally important to the success of INTEGRIS Health. He appreciates the time and effort you have devoted in delivering quality care to our patients. INTEGRIS Health Partners is committed to making sure that the physician’s voice is heard.

Thank you all for your hard work the past year. I also want to thank you on a personal level for all your prayers and support during the last year. I am feeling great and probably better than ever. Always remember if we keep our focus on the patient and put their needs at the center of everything we do, success will follow.

Sincerely,
Carl Raczkowski, M.D.
President, INTEGRIS Health Partners
________________________________________

New Clostridium difficile Testing Orders Effective Jan. 17

Fall 2018, the Infection Prevention Care Transformation Team made recommendations to improve appropriate utilization of C. difficile testing based on a review of current evidence based guidelines. That recommendation was approved by the physician membership of the Clinical Leadership Transformation Council in December 2018.

Effective Jan. 17, 2019, a C. difficile order update will go into effect. The order set update will include the following.

Based on day of admission, there are two phases to the order set.

• Early phase (through hospital day three, based on calendar day) requires notation of a single episode of loose, watery diarrhea for testing consideration.
• Late phase (hospital day four and beyond) requires notation of three episodes of watery or loose diarrhea without etiology (i.e., bowel prep, laxatives in last 48 hours) and additional clinical indication. Note: an acknowledgement click is required if you choose to test without meeting this evidence-based criteria.

DLO will reject samples that do not meet Bristol Stool Chart 6 and 7 criteria for C. difficile testing.

The tip sheet for this update is attached, available here and the physician learning home dashboard in the What's New section. Questions? rebecca.lewis@integrisok.com
________________________________________

Diabetic Metric for 2019: Medical Attention for Nephropathy

Any of the following meet the criteria for a nephropathy screening or monitoring test
1. Urine test for albumin or protein
a. 24 – hour urine for albumin or protein
b. Timed urine for albumin or protein
c. Spot urine (e.g. urine dipstick or test strip) for albumin or protein
d. Urine for albumin/creatinine ration
e. 24 – hour urine for total protein
f. Random urine for protein/creatinine ratio

CPT codes that would satisfy the above requirements are 82042, 82043, 82044, 84156, 81000, 81001, 81002, 81003, 81005

2. Documentation of a visit to a nephrologist in the current year
3. Documentation of a renal transplant
4. Evidence of ACE inhibitor/ARB therapy. Documentation in the medical record must include at minimum, a note indicating that the member received an ambulatory prescription for ACE inhibitors/ARBs in the current year.
5. Documentation of medical attention for any of the following:
a. Diabetic nephropathy
b. ESRD
c. Chronic renal failure
d. Chronic kidney disease
e. Renal insufficiency
f. Proteinuria
g. Albuminuria
h. Renal dysfunction
i. Acute renal failure
j. Dialysis, hemodialysis or peritoneal dialysis
________________________________________

In-network Orthopedic Surgeons

As of January 1, 2019, Orthopedic Associates is no longer part of the INTEGRIS Health Partners network. It is our understanding that all of the physicians will be part of a new orthopedic group owned by Mercy. Andrew Parkinson, M.D. will remain independent and continue to be a member of the IHP network. His new practice location is 14100 Parkway Commons Drive, Suite 101, Oklahoma City, OK, 73134.

Attached is a list of in-network IHP orthopedic surgeons. Please contact IHP care coordination at 405-951-2504 for specific questions about in-network orthopedic services.
________________________________________

INTEGRIS Connect Welcome

Dr. Thara Damodaran, infectious disease, and Dr. Bradley Kropp, Dr. William Reiner, and nurse practitioner Jake Kline, pediatric urology, are the latest independent providers to implement INTEGRIS Connect, the Epic product for community providers. Dr. Damodaran, Dr. Kropp, Dr. Reiner, and Mr. Kline, and their staff members can now access information for their shared patients throughout the Epic system. Congratulations! To learn more about INTEGRIS Connect, visit www.integrisok.com/connect. Submit an inquiry to schedule an informational meeting.
________________________________________

Pharmacy Update

The current formulary is available for review here: https://integrisok.com/ihp/pharmacy-task-force

Please contact INTEGRIS Health Partners Care Coordination at 403-951-2504 or toll free at 855-582-3003 for more information.
________________________________________

New Physicians and Advanced Practice Providers